Submitted by kBLASTER Team on
Vital Art and Science, developers of myVisionTrack, a vision test service for patients with age-related macular degeneration or diabetic eye disease, has received a second FDA 510(k) clearance for their platform, which includes an app and a provider dashboard. They will also soon launch a major clinical trial in partnership with the Scripps Translational Science Institute and Roche, according to the study’s website.
Trying to determine if a digital health app or wearable is a FDA regulated medical device? kBLASTER® search can help determine the FDA jurisdiction status of your digital health product. Leverage kBLASTER® consulting experience on FDA guidances regarding mobile medical applications, general wellness products and medical device data systems to navigate a path for a non-FDA regulated product.
Looking for the cornerstone to a successful 510(k) clearance strategy? kBLASTER® FDA 510(k) search can quickly identify the best available primary predicate, multiple predicates or reference devices and manage those results effectively.